• US: +1 9176726599
  • Login
  • Home
  • >> others
  • >> Extracorporeal Membrane Oxygenation Mach...

Extracorporeal Membrane Oxygenation Machine Market Status (2018-2022) and Forecast Market Analysis, Regional Outlook, Segment Growth Potential, and Competitive Market Share Analysis, 2023-2030

Format: PDF | Pages: 275 | Report ID: MRS1257


Report Description

The global Extracorporeal Membrane Oxygenation Machine market size was valued at USD 630.8 million in 2022, expanding at a CAGR of 4.2% from 2023-2030 to reach 1,280.4 Million USD in 2030.

Market Dynamics

The market Extracorporeal Membrane Oxygenation Machine market is expected to have substantial growth over the forecast period. One of the reasons driving the market expansion is the expanding number of hospitals providing ECMO services as well as the rising number of awareness initiatives. The Federal Agency for Health Research & Quality reports that 6890 ECMO procedures were carried out in the United States in 2014. Following then, extracorporeal membrane oxygenation (ECMO) machines have become much more widely used in hospitals. The Extracorporeal Life Support Organization (ELSO) reports that 264 hospitals now offer ECMO treatments, up from 108 in 2008.

Serious COVID-19 patients are being treated with ECMO devices. In 2020, there was a substantial reduction in the use of these devices for heart treatments, among other uses. The market is expanding as a result of rising knowledge of ECMO techniques and technical advancement.

In addition, the use of ECMO equipment is being accelerated by the growing elderly population and the frequency of coronary heart disease. One of the top reasons of death worldwide and significantly correlated with advancing age is coronary heart disease. The United Nations estimate that there will be 426 million persons 80 years of age or older on the planet in 2050, up from 143 million in 2019. The market, however, may be hampered by ECMO machine side effects such as infections, technical problems, bleeding, and costly treatment costs.

Regional Insights

In 2022, North America led the market thanks to the presence of key competitors and new product introductions. The government's support for high-quality healthcare, the region's high purchasing power parity, and the rising prevalence of chronic obstructive pulmonary disease-like conditions in the United States and Canada are all factors contributing to the market's expansion. The availability of advanced medical facilities and benevolent reimbursement practices has increased hospital admittance rates, which is anticipated to enhance usage rates in this area.

During the projected period, the extracorporeal membrane oxygenation market in Asia-Pacific is anticipated to develop at the quickest rate. The increase in healthcare spending by the government and private organizations to develop healthcare facilities is one of the main reasons fueling the expansion of this region. The expansion of the market is also anticipated to be aided by the economic development of nations like Japan, India, and China, as well as growing government attempts to improve healthcare infrastructure and reimbursement practices.

Segment Dynamics

The Extracorporeal Membrane Oxygenation Machine market is fragmented into component, modality, and application segments. Based on the component, the pump segment is anticipated to dominate the market. By modality, the veno arterial segment of the market is projected to grow at the highest CAGR during the forecasted period. By application, the respiratory segment is expected to hold the majority of the market share.

Competitive Insights

The market for extracorporeal membrane oxygenators is quite competitive due to the presence of both domestic and foreign companies. To stay competitive in the market, major businesses in the sector create new products, form collaborations, and engage in strategic mergers and acquisitions. For instance, the Xenios Console and patient kits for ECMO therapy were approved by the National Medical Products Administration (NMPA) in China in July 2022 by Xenios AG.

In the section that follows, after giving a general overview of the industry chain structure and a description of the current business climate, the market size and forecast for extracorporeal membrane oxygenation machines are examined by type, region, and application. Also, this study includes the value chain characteristics, market pricing analysis, company profiles, and the state of vendor competition in the market.

Company Coverage (Business Profile, Sales Revenue, Pricing, Gross Margin, Major Products, etc.):

  • Medtronic plc
  • Sorin Group
  • Terumo Cardiovascular Systems Corporation
  • MAQUET Holding B.V. & Co. KG
  • Medos Medizintechnik AG
  • Nipro Medical Corporation
  • Microport Scientific Corporation
  • Fresenius Medical care AG & Co. KGaA
  • Xenios AG

Covering of the following components: Major Consumer Analysis; Market Size and Forecast; etc.

  • Pumps
  • Oxygenator
  • Controllers
  • Cannula
  • Accessories

Covered by Modality (Market Size & Forecast, Major Customer Analysis, etc.):

  • Veno-Arterial
  • Veno-Venous
  • Arterio-Venous

Coverage of the Major Consumer Analysis, Market Size & Forecast, and Other Applications:

  • Respiratory
  • Neonates
  • Pediatric
  • Adult

Coverage of Regional Markets (Regional Consumption, Demand, and Forecast by Countries, etc.)

  • North America (U.S., and Canada)
  • Europe (Germany, U.K., France, Italy, Spain etc.)
  • Asia-Pacific (China, India, Japan, Indonesia, Malaysia, Australia, South Korea, etc.)
  • South America (Brazil, Mexico, Argentina etc.)
  • Middle East & Africa (Saudi Arabia, Kuwait, UAE, South Africa etc.)

Frequently Asked Questions

The market for extracorporeal membrane oxygenation devices was valued at USD 630.8 million in 2022 and is expected to grow at a CAGR of 4.2% from 2023 to 2030 to reach USD 1,280.4 Million.
North America generated the most revenue in 2021, and it is anticipated that it will hold this position throughout the study period.
From 2023 to 2030, the market for extracorporeal membrane oxygenators will grow at a CAGR of 4.2%, reaching a value of 1,280.4 million USD.
Asia Pacific (especially China, and India) region is projected to grow at the fastest growth rate during the study period.
The Extracorporeal Membrane Oxygenation Machine market is highly competitive in nature with the presence of local & international players. Major players in the industry engage in strategic merger & acquisition, partnership, and new product launches to remain competent in the market. For example, in July 2022, Xenios AG received approval from the National Medical Products Administration (NMPA) in China for the Xenios Console and patient kits for ECMO therapy.

Why Choose Market Research Strategy?

  Authenticated Data Sources

We utilize market analysis/information from verified authenticated data sources to scoop accurate research reports

  Express Delivery

We understand the urgency of our clients and their clients' in the competitive space thus, deliver the report in minimum turnaround

  Gain Instant Access

Without further ado, choose us and get instant access to reliable analysis to help you make the right business decisions.

  Our Pledge to You

We abide by the information security policy and adheres to keep your private and business information confidential and secure.

Copyright © 2022 Market Research Strategy, All rights reserved.